doctor head
 
  pharmacy and drugs  
search Search
 
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
 
  doctor legs  
 
 
 
 

  Diseases

  Newsletter
Subscribe to our newsletter:
Name:
E-mail:

    Mometasone inhalation
Mometasone inhalation Mometasone inhalation review
by
Pharmacy and Drugs


     .: Prescription

Mometasone inhalation belong to a class of drug known as corticosteroid. It prevents the release of substances in the body that cause inflammation. Mometasone inhalation is used to prevent attacks of bronchial asthma.

Important information on mometasone inhalation:
1. This drug will not stop an asthma attack that has already started but it is used to prevent subsequent attacks from occurring.
2. It may take several weeks before you see the therapeutic effects of this drug. Therefore, do not use more of this medication than is prescribed, but use it consistently, as directed, even when you are feeling better. Talk to your doctor if your symptoms do not improve or if they get worse.
3. Proper inhaler is very important so that the medicine gets into the lungs.
4. If you notice that you require more than your usual or more than the maximum amount of any asthma medication in a 24-hour period, talk to your doctor. An increased need for medication could be an early sign of a serious asthma attack.
5. Mometasone inhalation is not a substitute for an oral steroid. Continue to take any oral steroid (pills or liquid) that your doctor has prescribed.
6. If you are shifting from an oral steroid (pills or liquid) to mometasone inhalation, wear identification that will let others know that you may require a systemic steroid during a severe asthma attack. Inform your doctor before you discontinue an oral steroid.

Special precautions: You may not be able to use mometasone inhalation if you have a serious infection such as viral, bacterial, or fungal infection. The absorption of this drug into the system can inhibit the body's ability to fight off infections. Be cautious and discuss to your doctor if you are pregnant or could become pregnant during treatment as well as if you are breast-feeding a baby. Mometasone inhalation is in the FDA pregnancy C which means that is not known whether mometasone inhalation will be harmful to an unborn baby. It is also not known whether mometasone passes into breast milk.

An overdose of this medication is not likely to occur but the body’s immune system may not be strong enough to fight off an infection while using mometasone inhalation. It is better to avoid exposure to known sources of infection (e.g. chickenpox and measles).

Serious side effects from mometasone inhalation are not likely to occur. These include: an allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives); numbness, tingling, or pain; a rash or unexplained open sores or bruising; or worsening respiratory symptoms.

Other, less serious side effects may be more likely to occur. Continue to take mometasone inhalation and talk to your doctor if you experience: dryness of the mouth, nose, or throat after use; yeast infection in the mouth or throat (white patches); hoarseness or deepening of the voice, cough, or sore throat; wheezing; increased pressure in the eyes, glaucoma, or tearing of the eyes; headache or lightheadedness; unpleasant (or loss of) taste or smell; decreased growth in children taking large doses; or cataracts (long-term use).

Drug interactions: use of other oral, nasal, or inhaled steroids that may increase the chance of side effects or overdose. Discuss with your doctor and pharmacist before taking any prescription or over-the-counter medicines, including vitamins, minerals, and herbal products to avoid possible drug interactions.

Mometasone furoate is a white powder with an empirical formula of C27H30Cl2O6, and molecular weight 521.44 Daltons. The ASMANEX TWISTHALER 220 mcg product is a cap-activated inhalation-driven multi-dose dry powder inhaler containing mometasone furoate and anhydrous lactose (which contains milk proteins). Each actuation of the ASMANEX TWISTHALER 220 mcg inhaler provides a measured dose of 1.5 mg mometasone furoate inhalation powder, containing 220 mcg of mometasone furoate. This results in delivery of 200 mcg mometasone furoate from the mouthpiece, based on in vitro testing at flow rates of 30 L/min and 60 L/min with constant volume (2L). The amount of mometasone furoate emitted from the inhaler in vitro did not differ significantly for flow rates ranging from 28.3 L/min to 70 L/min for fixed intervals of 2 seconds. However, the amount of drug delivered to the lung will depend on patient factors such as inspiratory flow and peak inspiratory flow through the device. In adult and adolescent patients with varied asthma severity, mean peak inspiratory flow rate through the device was 69 L/min (range 54-77 L/min).

Mometasone inhalation has the following structural formula:

Chemical structure of Mometasone inhalation
Brand name: Asmanex :: Twisthaler

Similar drugs: Combivent :: Fexofenadine :: Accolate

  Add Comment
Tell others what you thought about Mometasone inhalation.

Nick: Score:
Text:

2006-2012 pharmacy-and-drugs.com. All rights reserved.